Unity Biotechnology, Inc.
UBX
Revenue
0.00
0.000.00%
9 Months ChangeAssets
53.52M
▼-5.34M▼-9.07%
3 Months ChangeLiabilities
33.77M
▼-1.11M▼-3.17%
3 Months ChangeFree Cash Flow
-14.97M
▲133.00k▲0.8805%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0000950170-24-091903
2024-08-06
Form 8-K
ID: 0000950170-24-091890
2024-06-21
Form 8-K
ID: 0000950170-24-076214
2024-05-14
Form 10-Q
ID: 0000950170-24-059765
2024-05-14
Form 8-K
ID: 0000950170-24-059749
2024-04-15
Form 8-K
ID: 0000950170-24-044230
2024-03-20
Form 8-K
ID: 0000950170-24-034175
2023-11-13
Form 10-Q
ID: 0000950170-23-062923
2023-11-13
Form 8-K
ID: 0000950170-23-062912
2023-11-13
Form 8-K
ID: 0000950170-23-062417